European ministers will wait until after E.U. health officials' meeting today to decide whether or not to impose a ban on travel. But is a full-on travel ban really necessary? Christopher Werth reports.
It's not just people getting sick with the swine flu — it's also hurting the global economy. Mitchell Hartman reports on the outbreak's economic impact worldwide.
As people ask what they can do to stay vigilant against the potential swine flu pandemic, the office has become a major area of concern. Jennifer Collins tells us how businesses are responding to the outbreak.
Many are concerned about the effects a swine flu pandemic could have on an already ailing U.S. economy. But commentator Robert Reich says the real worry is that lots of people could get sick and many could die.
While investment in biotech is down, health care information technology is holding its own. Investors are following the $20 billion in President Obama's stimulus plan to upgrade and modernize health records. Mitchell Hartman reports.
Mexico's economy is taking a beating with high unemployment and drug violence. Now add the swine flu outbreak to the list. Dan Grech reports on how the flu outbreak is hurting Mexico's already weak economy.
North American passengers arriving in Asia are having their temperature taken, while the U.S. screens for signs of swine flu at the Mexican border. Steve Henn reviews how the world is moving to control the pandemic.
Drug manufacturers Roche and GlaxoSmithKline are seeing a rise in the markets this morning on the continued worldwide reaction to swine flu. Both drug makers are ready to deploy their stockpiles. Christopher Werth reports.
When drug maker Roche bought Genentech, it was counting on the success of the pharmaceutical company's cancer drug Avastin. But the drug didn't prevent the recurrence of colon cancer in clinical tests. Janet Babin reports.
